The following day, on the opposite Coastline, Johns Hopkins University scientists published final results from the 1st randomized controlled demo of managing major depressive dysfunction with synthetic psilocybin.The truth that lots of placebo-takers documented benefits “calls into issue The full phenomenon of microdosing,” he says.Learn about